Decitabine/cedazuridine: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

7

Conditions studied

1

US states with sites

1

Countries

Phase breakdown

Phase 2 1

Conditions being studied

Condition	Trials
BRCA1-Associated Protein-1 (BAP1) Mutations	1
Early-stage BAP1-associated Malignancies	1
Early-stage Mesothelioma	1
Lung cancer	1
Malignant Mesothelioma (MM)	1
Mesothelioma	1
Subclinical Mesothelioma	1

Recruiting trials involving Decitabine/cedazuridine

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
NCT05960773 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Decitabine/cedazuridine?

1 recruiting trial across 7 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.